Lloyd Price

FEBRUARY 7, 2025

Factors to Consider When Assessing Management Quality Experience: The management team's experience in the healthcare industry, particularly in relevant areas such as drug development, medical device manufacturing, or healthcare services, can be a significant advantage.

healthcare technology 69

healthcare technology Leadership Drug Development Pharmaceuticals 69

Digital Health Global

JANUARY 28, 2025

In related news, Medable announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium that links decentralized clinical trial approaches to higher participation rates across multiple demographic groups. 5 at 9:55am.

Life Science 88

Life Science Drug Development Digital Health 88

Digital Health Global

JANUARY 29, 2025

28, 2025 with the following corrected version due to multiple revisions. Tenaerts will be available at the 2025 SCOPE event in Orlando, FL, booth #717, to discuss the PACT Consortium findings. PALO ALTO, Calif.–(BUSINESS –(BUSINESS WIRE)–Please replace the release dated Jan. Medable Inc., Medable Inc., 5 at 9:55am.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Digital Health Global

JANUARY 28, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium links decentralized clinical trial (DCT) approaches to notably higher participation rates across multiple demographic groups. PALO ALTO, Calif.–(BUSINESS

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Healthcare IT Today

MARCH 3, 2025

That doesn’t just lead to faster trials, it changes the way companies can think about drug development going from waterfall big bets to agile research.” Originally announced January 22nd, 2025 . “We’re fixing that with a new paradigm for running trials underpinned by technology.

Life Science 85

Life Science Psychiatry Drug Development Digital Health 85

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Lloyd Price

OCTOBER 9, 2024

Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy Neuroscience innovation primed for mainstream growth in 2025 2025 is poised to be a pivotal year for neuroscience, with groundbreaking advancements poised to enter the mainstream.

Mental health 60

Mental health healthcare technology Leadership Digital Health 60

Healthcare IT Today

FEBRUARY 24, 2025

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut Drug Development Timelines and Costs, Transforming Cancer and Rare Disease Treatments Company Raises $24.6 Originally announced January 27th, 2025 Visit manasai.co

Life Science 59

Life Science Drug Development Health IT Healthcare IT 59

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. 2025: the year to bridge the 4 Big Gaps in HealthTech?

Interoperability 72

Interoperability healthcare technology HIPAA Leadership 72

Healthcare IT Today

JANUARY 22, 2025

So as 2025 begins, let’s all strive to reduce disparities and promote health equity in underserved communities this year! Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drug development and discovery process.

EHR 82

EHR Drug Development Remote care Interoperability 82

Healthcare IT Today

JANUARY 3, 2025

As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions !

Health IT 92

Health IT Pharmaceuticals Drug Development Life Science 92

Lloyd Price

JANUARY 20, 2025

In 2025, B2C2B models are poised to become increasingly prominent in healthcare, driven by several key factors: Digital Health Boom: The rapid growth of digital health technologies, such as telehealth, wearable devices, and AI-powered diagnostics, is creating new opportunities for B2C2B companies to reach both patients and healthcare providers.

Mental health 60

Mental health healthcare technology Telehealth Digital Health 60

Lloyd Price

JUNE 4, 2018

CVC’s recent acquisition of the women’s health division of the Israeli drug developer Teva for $800m created a company dedicated to contraception, fertility, menopause and osteoporosis. Recent analysis from Frost and Sullivan shows this market to be worth up to $50bn by 2025.

Mental health 49

Mental health Drug Development Health Data 49

Lloyd Price

DECEMBER 11, 2023

It stated: ‘By 2025, global spend on digital health is predicted to reach €1tn and digital products and services will grow to a market share of 12% (Choueiri et al., Digital health companies can help identify new drug targets, design clinical trials and analyse data more effectively.

Pharmaceuticals 63

Pharmaceuticals Digital Health Drug Development Life Science 63

Healthcare IT Today

DECEMBER 31, 2024

As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions !

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65

Healthcare IT Today

FEBRUARY 25, 2025

This is the pathway toward achieving human digital twins, dynamic models that not only reflect and allow health monitoring but also enhance patient stratification, improve the success rates of drug development programs, and enable treatment testing before application. Originally announced January 28th, 2025

Pharmaceuticals 66

Pharmaceuticals Drug Development Health IT Healthcare IT 66

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A Source: Markets and Markets “Digital Pathology Market, Global Forecast to 2025”; Signify Research “Digital Pathology – World – 2018”.

Pharmaceuticals 69

Pharmaceuticals Drug Development Medical Technology Healthcare IT 69

Digital Health Wire

DECEMBER 18, 2024

The task force started by highlighting AIs potential across a long list of use cases, which could have been the tracklist for healthcares greatest hits of 2024: Drug Development – 300+ drug applications contained AI components this year. Ambient AI – Burnout is bad. Patient time is good.

Leadership 52

Leadership Drug Development Interoperability Digital Health 52